|
|
|
Bluejay Diagnostics Inc (NASDAQ: BJDX) |
|
Bluejay Diagnostics Inc
BJDX's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Bluejay Diagnostics Inc's sales fell
in the first quarter of 2025 from the same quarter a year ago.
Medical Equipment & Supplies industry recorded
deterioration of revenues by -0.36 %
Bluejay Diagnostics Inc net loss decreased from $-2 millions, to $-2 millions in first quarter of 2025,
• More on BJDX's Growth
|
|
Bluejay Diagnostics Inc
realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 2.03 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.21.
• More on BJDX's Valuation
|
|
|
|
|
Bluejay Diagnostics Inc
realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 2.03 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.21.
Bluejay Diagnostics Inc Price to Book Ratio is at 0.24 higher than Industry Avg. of -587.75, and higher than S&P 500 Avg. of 0.01
• More on BJDX's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
